Previous close | 12.54 |
Open | 12.61 |
Bid | 11.40 |
Ask | 13.85 |
Strike | 4.00 |
Expiry date | 2026-01-16 |
Day's range | 12.54 - 12.61 |
Contract range | N/A |
Volume | |
Open interest | 106 |
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
After disappointing sales for their Covid vaccines last year, drugmakers are hoping for an August rollout of the updated shot.